| Metric | Value ($ M) | Q2 FY25 | Q3 FY24 |
|---|---|---|---|
| Revenue | 70.45 | 70.5% | 16.6% |
| Total Income | 70.45 | 70.5% | 16.6% |
| Expenditure | 248.46 | 79.8% | 13.7% |
| PBT | -203.04 | 289.0% | 66.0% |
| Net Profit | -202.38 | 290.0% | 66.8% |
| OPM | — | ||
| NPM | — | ||
| EPS | -1.25 | 289.4% | 64.5% |
Novavax Reports Q3 2025 Financial Results
04 May 2026 · 4 May, 7:45 am
Summary
Novavax, Inc. announced its financial results for the quarter ended September 30, 2025, as detailed in a press release issued on November 6, 2025. The press release, attached as Exhibit 99.1 to the Current Report on Form 8-K, contains information regarding the company's financial performance during this period.
Key Highlights
- 1
Novavax, Inc. announced its financial results for the quarter ended September 30, 2025.
- 2
The press release provides details on the company's performance during the third quarter.
Informational and educational content only. Not investment advice.